Senter PD - Search Results

1

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.

Senter PD, Saulnier MG, Schreiber GJ, Hirschberg DL, Brown JP, Hellström I, Hellström KE. Senter PD, et al. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4842-6. doi: 10.1073/pnas.85.13.4842. Proc Natl Acad Sci U S A. 1988. PMID: 3387440 Free PMC article.

2

Activation of prodrugs by antibody-enzyme conjugates.

Senter PD, Wallace PM, Svensson HP, Kerr DE, Hellstrom I, Hellstrom KE. Senter PD, et al. Adv Exp Med Biol. 1991;303:97-105. doi: 10.1007/978-1-4684-6000-1_12. Adv Exp Med Biol. 1991. PMID: 1805578 No abstract available.

3

Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates.

Senter PD, Su PC, Katsuragi T, Sakai T, Cosand WL, Hellström I, Hellström KE. Senter PD, et al. Bioconjug Chem. 1991 Nov-Dec;2(6):447-51. doi: 10.1021/bc00012a012. Bioconjug Chem. 1991. PMID: 1805942

4

Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.

Kerr DE, Senter PD, Burnett WV, Hirschberg DL, Hellström I, Hellström KE. Kerr DE, et al. Among authors: senter pd. Cancer Immunol Immunother. 1990;31(4):202-6. doi: 10.1007/BF01789169. Cancer Immunol Immunother. 1990. PMID: 2116231 Free PMC article.

5

Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates.

Senter PD, Schreiber GJ, Hirschberg DL, Ashe SA, Hellström KE, Hellström I. Senter PD, et al. Cancer Res. 1989 Nov 1;49(21):5789-92. Cancer Res. 1989. PMID: 2790791

6

Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD. Kerr DE, et al. Among authors: senter pd. Cancer Res. 1995 Aug 15;55(16):3558-63. Cancer Res. 1995. PMID: 7627964

7

The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity.

Abraham R, Moller D, Gabel D, Senter P, Hellström I, Hellström KE. Abraham R, et al. J Immunol Methods. 1991 Nov 5;144(1):77-86. doi: 10.1016/0022-1759(91)90233-6. J Immunol Methods. 1991. PMID: 1660058

8

Activation of prodrugs by targeted enzymes.

Hellström KE, Senter PD. Hellström KE, et al. Among authors: senter pd. Eur J Cancer. 1991;27(11):1342-3. doi: 10.1016/0277-5379(91)90003-v. Eur J Cancer. 1991. PMID: 1835844 No abstract available.

9

Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers.

Senter PD, Svensson HP, Schreiber GJ, Rodriguez JL, Vrudhula VM. Senter PD, et al. Bioconjug Chem. 1995 Jul-Aug;6(4):389-94. doi: 10.1021/bc00034a008. Bioconjug Chem. 1995. PMID: 7578358

10

Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate.

Kerr DE, Garrigues US, Wallace PM, Hellström KE, Hellström I, Senter PD. Kerr DE, et al. Among authors: senter pd. Bioconjug Chem. 1993 Sep-Oct;4(5):353-7. doi: 10.1021/bc00023a008. Bioconjug Chem. 1993. PMID: 8274519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters